Hydroxyapatite Scaffold and Bioactive Factor Combination as a Tool to Improve Osteogenesis, In Vitro and In Vivo Experiments Using Phage Display Technology
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26157040 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Debora Lo Furno und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical and Biotechnological Sciences (BIOMETEC), University of Catania, Via Santa Sofia 97, 95123 Catania, Italy. Hauptthemen laut MEDLINE: Osteogenesis, Durapatite, Tissue Scaffolds. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian PON Project-BONE++, Development of Micro and Nanotechnologies for Predictivity, Di-agnosis, Therapy and Regenerative Treatments of Pathological Bone an…, Italian PON Project–BONE++, Development of Micro and Nanotechnologies for Predictivity, Diagnosis, Therapy and Regenerative Treatments of Pathological Bone and….
Abstract (Originalsprache)
Mesenchymal stem cells have been widely investigated in the field of regenerative medicine and also used as a model to study the differentiation-induction properties of a variety of biomaterials. This study evaluates the osteoinductive potential of novel hydroxyapatite scaffolds functionalized with a phage-displayed peptide (SC1) selected via biopanning for its similarity to bone matrix proteins. The peptide, identified through sequence alignment as a mimotope of osteonectin (SPARC), was used to functionalize scaffolds. Results from SC1 were gathered at different time points (14, 28 and 46 days) and compared with those from nonfunctionalized hydroxyapatite (HA) scaffolds. In vitro experiments, by seeding human adipose-derived stem cells (hASCs), indicated satisfactory biocompatibility for both types of scaffolds. Histochemical observations showed that SC1, better than HA scaffolds, was able to improve hASC osteogenic differentiation, as evaluated through Alizarin Red staining (showing on average a darker staining of 100%). An increase was also observed, especially at early stages (14 days), for osterix (up to 60% increase) and osteonectin immunoexpression (up to 50% increase). In in vivo experiments, cell-free scaffolds of both types were subcutaneously implanted into the backs of mice and analyzed after 2, 4, 8 and 16 weeks. Also, in this case, SC1 more effectively promoted the osteogenic differentiation of infiltrated resident cells. In particular, increased immunoexpression of osterix and osteonectin (+30% and 35%, respectively) was found already at 2 weeks. It can be concluded that SC1 scaffolds may represent a valuable tool to address critical-sized bone defects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical and Biotechnological Sciences (BIOMETEC), University of Catania, Via Santa Sofia 97, 95123 Catania, Italy.
- Department of Chemical, Biological, Pharmaceutical and Environmental Sciences (ChiBioFarAm), University of Messina, Viale F. Stagno d'Alcontres 31, 98166 Messina, Italy.
- Department of Medicine and Surgery, University of Enna "Kore", 94100 Enna, Italy.
- Department of Medical, Surgical Sciences and Advanced Technologies "G.F. Ingrassia", Anatomic Pathology, University of Catania, Via Santa Sofia 87, 95123 Catania, Italy.
- Fin-Ceramica Faenza SPA, Via Granarolo 177/3, 48018 Faenza, Italy.
- Department of Chemistry "Giacomo Ciamician", University of Bologna, Via Selmi 2, 40126 Bologna, Italy.
ORCID-Profile: Debora Lo Furno, Maria Giovanna Rizzo, Giuliana Mannino, Giovanna Calabrese, Rosario Giuffrida, Simona D'Aprile, Rosalba Parenti
Förderung
- Italian PON Project-BONE++, Development of Micro and Nanotechnologies for Predictivity, Di-agnosis, Therapy and Regenerative Treatments of Pathological Bone an…
- Italian PON Project–BONE++, Development of Micro and Nanotechnologies for Predictivity, Diagnosis, Therapy and Regenerative Treatments of Pathological Bone and…
Zitieren
APA
Lo Furno, D., Romano, I. R., Russo, V., Rizzo, M. G., Mannino, G., Calabrese, G., Giuffrida, R., D'Aprile, S., Salvatorelli, L., Magro, G., Bendoni, R., Dolcini, L., Zappalà, A., Guglielmino, S. P. P., Conoci, S., & Parenti, R. (2025). Hydroxyapatite Scaffold and Bioactive Factor Combination as a Tool to Improve Osteogenesis, In Vitro and In Vivo Experiments Using Phage Display Technology. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26157040
Vancouver
Lo Furno D, Romano IR, Russo V, Rizzo MG, Mannino G, Calabrese G, et al. Hydroxyapatite Scaffold and Bioactive Factor Combination as a Tool to Improve Osteogenesis, In Vitro and In Vivo Experiments Using Phage Display Technology. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26157040
BibTeX
@article{LoFurno2025,
author = {Lo Furno, Debora and Romano, Ivana R and Russo, Vincenzo and Rizzo, Maria Giovanna and Mannino, Giuliana and Calabrese, Giovanna and Giuffrida, Rosario and D'Aprile, Simona and Salvatorelli, Lucia and Magro, Gaetano and Bendoni, Riccardo and Dolcini, Laura and Zappalà, Agata and Guglielmino, Salvatore P P and Conoci, Sabrina and Parenti, Rosalba},
title = {Hydroxyapatite Scaffold and Bioactive Factor Combination as a Tool to Improve Osteogenesis, In Vitro and In Vivo Experiments Using Phage Display Technology},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26157040}
}
EUVIMED